These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7169673)

  • 1. Mycobacterial carrier and antitumour activity of the combination: BCG-cyclophosphamide.
    Hiu IJ
    Jpn J Exp Med; 1982 Dec; 52(6):287-90. PubMed ID: 7169673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoimmunotherapy of murine bladder cancer.
    Stogdill BJ; Lamm DL; Livingston RB
    Invest Urol; 1981 Nov; 19(3):179-81. PubMed ID: 7298287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of BCG as immunoadjuvant in combination with antitumor drugs in a virus induced leukemia. II].
    Perito S; Cenci E; Sbaraglia G; Vecchiarelli A
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2511-7. PubMed ID: 7470294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions.
    D'Agostini C; Pica F; Febbraro G; Grelli S; Chiavaroli C; Garaci E
    Int Immunopharmacol; 2005 Jul; 5(7-8):1205-12. PubMed ID: 15914325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY; Singh B
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modification of macrophage activity in experimental granulomas by cyclophosphamide.
    Birman EG; Mariano M
    J Pathol; 1981 Jun; 134(2):133-46. PubMed ID: 7252645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of the immune strategy based on BCG priming and Ag85A/GM-CSF DNA vaccine boosting in mice].
    Tang Q; Dou J; Zhao FS; Chu LL; Pan M; Wang YF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):591-4. PubMed ID: 17618574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
    Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia].
    Sbaraglia G; Cenci E; Vecchiarelli A; Perito S
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1969-75. PubMed ID: 7459108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril augments antitumor activity of cyclophosphamide in mice.
    Kowalski J; Herman ZS
    Pol J Pharmacol; 1996; 48(3):281-5. PubMed ID: 9112663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide.
    Wang Z; Zheng Q; Liu K; Li G; Zheng R
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):411-5. PubMed ID: 16623867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
    Burns ER; Scheving LE
    Chronobiologia; 1980; 7(1):41-51. PubMed ID: 7438892
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomide.
    Ding Q; Kestell P; Baguley BC; Palmer BD; Paxton JW; Muller G; Ching LM
    Cancer Chemother Pharmacol; 2002 Sep; 50(3):186-92. PubMed ID: 12203100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.